Screening for Monoclonal B-Cell Lymphocytosis, a CLL Precursor - Dr. Susan Slager ASH 2021

Monoclonal B-cell lymphocytosis (MBL) is the common chronic lymphocytic leukemia (CLL) precursor condition. It is characterized by a circulating population of clonal B-cells with an absolute B-cell count 5×10^9/L, the normal count with clonal cells, and no evidence of enlarged lymph nodes, spleen, or low blood counts. These clonal B-cells are usually identical to the clonal B-cells in those with chronic lymphocytic leukemia (CLL). Mayo Clinic individuals who did not have a prior diagnosis of blood abnormality for MBL and followed their progression.
Dr. Susan Slager from Mayo Clinic, discusses results presented at the American Society of Hematology (ASH) 2021 annual meeting.
Read the full article on CLL Society's website at: cllsociety.org...
__________________________________________________________________________________________
CLL Society Website: cllsociety.org/
Facebook: / cllsociety
Twitter: / cllsociety
LinkedIn: / cll-society